Nathan Eddy
Tariffs and drug pricing reforms are a top priority, overtaking traditional concerns such as workforce challenges and cybersecurity.
Senior leaders feel pressure to evolve AI but cite a lack of internal resources to develop in-house AI tools.
Execs are eager to use genAI to optimize workflow and improve clinical sustainability, but a readiness gap persists.
The report identifies six major areas of payer-provider friction, largely revolving around VBC initiatives.
For AI to work in clinical care, doctors must be involved in decision-making with their patients, Philips report says.
Roughly 477,000 jobs could be lost in healthcare, including in hospitals, doctors' offices, clinics, pharmacies and nursing homes.
Inpatient revenue has grown at a faster rate than outpatient revenue, signaling a shift in hospital utilization patterns.
Payouts by public healthcare companies have tripled since 2001, report says.
One of VBC's biggest issues is its reliance on complex financial models instead of direct provider enablement.
Hospitals and drugmakers are urging the president to exempt pharmaceuticals and medical goods from his new tariffs on Chinese imports.